To evaluate the applicability of the Global Leadership Initiative on Malnutrition (GLIM) criteria in older patients with sepsis and to compare the predictive validity for 28-day mortality of different muscle mass assessment methods in the emergency department. Prospective cohort study. Emergency department. Older patients (≥65 years) with sepsis. Muscle mass was assessed using three methods: (1) the skeletal muscle index at the third lumbar vertebra (L3) on computed tomography (CT) scans; (2) calf circumference (CC), and (3) mid-upper-arm circumference (MAC). Cox regression analysis was performed to assess the association between the GLIM criteria and 28-day all-cause mortality. Additionally, the C-statistic, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate the predictive validity of the three instruments. Survival curves were assessed using the Kaplan-Meier method and compared using the log-rank test. A total of 598 patients with sepsis were included. The prevalence of malnutrition according to GLIM-CT, GLIM-CC, and GLIM-MAC was 53.3%, 63.0%, and 40.8%, respectively. Cox regression analysis revealed that the GLIM criteria were independent risk factors for all-cause 28-day mortality. Incorporation of GLIM-CT, GLIM-CC, or GLIM-MAC into a base model significantly improved the C-statistic. The model including GLIM-CT had the highest C-statistic, improving the C-statistic of the base model from 0.780 (95% confidence interval [CI]: 0.741-0.819) to 0.823 (95% CI: 0.789-0.857). This improvement in risk prediction was also confirmed via category-free NRI and IDI, suggesting that GLIM-CT had the best performance. Kaplan-Meier survival analysis showed that patients with malnutrition defined according to the GLIM criteria had a greater probability of 28-day mortality (log-rank, P < 0.001). Malnutrition, defined via any of the three methods, was predictive of 28-day mortality among older patients with sepsis in the emergency department. GLIM-CT had the best predictive validity.
Background: Sarcopenia has a high incidence in older patients with sepsis and is closely associated with poor prognosis, but its metabolic characteristics under this specific stress state remain unclear. This study aims to reveal the specific plasma metabolomic changes related to sarcopenia in older patients with sepsis. Methods: A prospective observational cohort design was adopted, involving 84 older patients with sepsis, who were divided into a sarcopenia group (35 cases) and a non-sarcopenia group (49 cases). Fasting plasma samples were collected within 24 h, and untargeted metabolomic analysis was performed using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technology. Multivariate statistical methods such as principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) were used to screen differential metabolites, and KEGG pathway enrichment analysis was conducted. Results: A total of 4,752 metabolites were identified, and 203 significantly differential metabolites were screened out (71 upregulated and 132 downregulated), indicating that the plasma metabolic profile of sarcopenic patients presents an “inhibitory” feature. The differential metabolites were mainly enriched in core pathways such as valine/leucine/isoleucine degradation, arachidonic acid metabolism, and steroid hormone synthesis. Specifically, metabolic pathways promoting muscle synthesis (such as steroid hormone and branched-chain amino acid metabolism) were generally downregulated, while pathways representing catabolism and injury (such as inflammatory mediator production) were significantly upregulated. Correlation analysis of differential metabolites revealed an interconnected metabolic disorder network. Conclusion: This study preliminarily reveals the unique plasma metabolic profile of elderly patients with sepsis complicated by sarcopenia, which is characterized by the impact on core pathways such as branched-chain amino acid degradation, steroid hormone synthesis inhibition, and arachidonic acid metabolism activation. These findings systematically depict the potential metabolic imbalance networks associated with this disease state, provide new clues for understanding its pathophysiological mechanisms, and offer an important theoretical basis and potential targets for the future development of early diagnostic biomarkers and targeted intervention strategies for this disease.